Skip to main content
Erschienen in: Pediatric Cardiology 8/2011

01.12.2011 | Original Article

Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events

verfasst von: Jeffrey P. Moak, Eric S. Leifer, Dorothy Tripodi, Saidi A. Mohiddin, Lameh Fananapazir

Erschienen in: Pediatric Cardiology | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to identify prognostic factors for an arrhythmic event (AE) in children with hypertrophic cardiomyopathy (HCM) without a previous AE. One hundred thirty-one nonconsecutive patients (≤20 years) with HCM but no previous AE were evaluated at the NIH Clinical Center from 1980 to 2001. At a median follow-up of 6.4 years, 22 patients experienced an AE [sudden death (SD) (n = 12), resuscitated cardiac arrest (n = 3), clinical sustained ventricular tachycardia (VT) (n = 2), and implantable cardiac defibrillator discharge (n = 5)], resulting in a 2% annual AE rate. Baseline factors that were most predictive in univariate risk analysis included ventricular septal thickness (ST) (P = 0.01), VT induction by programmed ventricular stimulation (PVS) (P = 0.01), age (P = 0.05), and presyncope/syncope (P = 0.05). In multivariate analysis, ST, age, presyncope/syncope, and PVS were not independently predictive of risk for an AE. However, the 5-year event rates for AE was 15% (95% CI: 5–23%) if ST ≥ 20 mm, 19% (95% CI: 6–31%) when age ≥ 13 years and ST ≥ 20 mm were combined together, and 23% (95% CI: 3–39%) when PVS and ST ≥ 20 mm were combined together. Of the various risk factors that were considered in our pediatric HCM cohort, ST and inducible VT were the most significant univariate predictors of risk for an AE. More traditional risk factors identified in older patients (family history of SD, VT on Holter, and exercise-induced hypotension) were not predictive of an AE in patients age under 21 years.
Literatur
1.
Zurück zum Zitat Alexander ME, Walsh EP, Saul JP, Epsein MR, Triedman JK (1999) Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 10:1033–1044PubMedCrossRef Alexander ME, Walsh EP, Saul JP, Epsein MR, Triedman JK (1999) Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 10:1033–1044PubMedCrossRef
2.
Zurück zum Zitat Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua, Berul CI (2004) Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 15:72–76PubMedCrossRef Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua, Berul CI (2004) Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 15:72–76PubMedCrossRef
3.
Zurück zum Zitat Anderson KP, Stinson EB, Derby GC, Oyer PE, Mason JW (1983) Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients. Am J Cardiol 51:811–816PubMedCrossRef Anderson KP, Stinson EB, Derby GC, Oyer PE, Mason JW (1983) Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients. Am J Cardiol 51:811–816PubMedCrossRef
4.
Zurück zum Zitat Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998PubMedCrossRef Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998PubMedCrossRef
5.
Zurück zum Zitat Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L (2003) Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 26:1887–1896PubMedCrossRef Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L (2003) Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 26:1887–1896PubMedCrossRef
6.
Zurück zum Zitat Brito D, Richard P, Isnard R, Pipa J, Komajda M, Madeira H (2003) Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with long follow-up. Rev Port Cardiol 22:1445–1461PubMed Brito D, Richard P, Isnard R, Pipa J, Komajda M, Madeira H (2003) Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with long follow-up. Rev Port Cardiol 22:1445–1461PubMed
7.
Zurück zum Zitat Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890PubMedCrossRef Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890PubMedCrossRef
8.
Zurück zum Zitat Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O’Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342:1937–1945PubMedCrossRef Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O’Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342:1937–1945PubMedCrossRef
9.
Zurück zum Zitat Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ (1998) Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 79:331–336PubMed Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ (1998) Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 79:331–336PubMed
10.
Zurück zum Zitat Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO, Weivoda PL, Trusty JM, Friedman PA, Hammill SC, Rea RF, Shen WK (2007) Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 18:483–487PubMedCrossRef Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO, Weivoda PL, Trusty JM, Friedman PA, Hammill SC, Rea RF, Shen WK (2007) Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 18:483–487PubMedCrossRef
11.
Zurück zum Zitat Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA (2007) Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Findings from the pediatric cardiomyopathy registry. Circulation 15:773–781CrossRef Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA (2007) Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Findings from the pediatric cardiomyopathy registry. Circulation 15:773–781CrossRef
12.
Zurück zum Zitat Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies J, Kim J, Price JF, Dreyer WJ, Towbin JA, Denfield SW (2009) Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 54:250–254PubMedCrossRef Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies J, Kim J, Price JF, Dreyer WJ, Towbin JA, Denfield SW (2009) Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 54:250–254PubMedCrossRef
13.
Zurück zum Zitat Dilsizian V, Bonow R, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796–804PubMedCrossRef Dilsizian V, Bonow R, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796–804PubMedCrossRef
14.
Zurück zum Zitat Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218PubMedCrossRef Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218PubMedCrossRef
15.
Zurück zum Zitat Elliott PM, Gimeno Blanes JR, Mahon NJ, Poloniecki JD, McKenna WJ (2001) Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357:420–424PubMedCrossRef Elliott PM, Gimeno Blanes JR, Mahon NJ, Poloniecki JD, McKenna WJ (2001) Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357:420–424PubMedCrossRef
16.
Zurück zum Zitat Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, Maron BJ, Epstein SE (1989) Electropysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 80:1259–1268PubMedCrossRef Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, Maron BJ, Epstein SE (1989) Electropysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 80:1259–1268PubMedCrossRef
17.
Zurück zum Zitat Frenneaux MP (2004) Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90:570–575PubMedCrossRef Frenneaux MP (2004) Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90:570–575PubMedCrossRef
18.
Zurück zum Zitat Geibel A, Brugada P, Zehender M, Stevenson W, Waldecker B, Wellens HJJ (1987) Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy. Am J Cardiol 60:738–739PubMedCrossRef Geibel A, Brugada P, Zehender M, Stevenson W, Waldecker B, Wellens HJJ (1987) Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy. Am J Cardiol 60:738–739PubMedCrossRef
19.
Zurück zum Zitat Greenberg SL, Mauricio Sánchez J, Cooper JA, Cain ME, Chen J, Gleva MJ, Lindsay BD, Smith TW, Faddis MN (2007) Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators. Pacing Clin Electrophysiol 30:1067–1075PubMedCrossRef Greenberg SL, Mauricio Sánchez J, Cooper JA, Cain ME, Chen J, Gleva MJ, Lindsay BD, Smith TW, Faddis MN (2007) Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators. Pacing Clin Electrophysiol 30:1067–1075PubMedCrossRef
20.
Zurück zum Zitat Hinkle LE, Thaler HT, Merke DP, Renier-Berg D, Morton NE (1988) The risk factors for arrhythmic death in a sample of men followed for 20 years. Am J Epidemiol 127:500–515PubMed Hinkle LE, Thaler HT, Merke DP, Renier-Berg D, Morton NE (1988) The risk factors for arrhythmic death in a sample of men followed for 20 years. Am J Epidemiol 127:500–515PubMed
21.
Zurück zum Zitat Jansson K, Dahlstrom U, Karlsson E, Nylander E, Walfridsson H, Sonnhag C (1990) The value of exercise test, Holter monitoring, and programmed electrical stimulation in detection of ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 13:1261–1267PubMedCrossRef Jansson K, Dahlstrom U, Karlsson E, Nylander E, Walfridsson H, Sonnhag C (1990) The value of exercise test, Holter monitoring, and programmed electrical stimulation in detection of ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 13:1261–1267PubMedCrossRef
22.
Zurück zum Zitat Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marçon F, Alexander ME, Walsh EP (2004) Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 109:1994–2000PubMedCrossRef Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marçon F, Alexander ME, Walsh EP (2004) Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 109:1994–2000PubMedCrossRef
23.
Zurück zum Zitat Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115:2474–2480PubMedCrossRef Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115:2474–2480PubMedCrossRef
24.
Zurück zum Zitat Kowey PR, Eisenberg R, Engel TR (1984) Sustained arrhythmias in hypertrophic cardiomyopathy. N Engl J Med 310:1566–1569PubMedCrossRef Kowey PR, Eisenberg R, Engel TR (1984) Sustained arrhythmias in hypertrophic cardiomyopathy. N Engl J Med 310:1566–1569PubMedCrossRef
25.
Zurück zum Zitat Krikler DM, Davies MJ, Fowland E, Goodwin JF, Evans RC, Shaw DB (1980) Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 43:245–251PubMedCrossRef Krikler DM, Davies MJ, Fowland E, Goodwin JF, Evans RC, Shaw DB (1980) Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 43:245–251PubMedCrossRef
26.
Zurück zum Zitat Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A (1988) Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 9:177–185PubMed Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A (1988) Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 9:177–185PubMed
27.
Zurück zum Zitat Lim PO, Morris-Thurgood JA, Frenneaux MP (2002) Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise. Cardiol Rev 10:15–23PubMedCrossRef Lim PO, Morris-Thurgood JA, Frenneaux MP (2002) Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise. Cardiol Rev 10:15–23PubMedCrossRef
28.
Zurück zum Zitat Lin G, Nishimura RA, Gersh GJ, Phil D, Ommen SR, Ackerman MJ, Brady PA (2009) Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 95:709–714PubMedCrossRef Lin G, Nishimura RA, Gersh GJ, Phil D, Ommen SR, Ackerman MJ, Brady PA (2009) Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 95:709–714PubMedCrossRef
29.
Zurück zum Zitat Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P (2000) Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373PubMedCrossRef Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P (2000) Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373PubMedCrossRef
30.
Zurück zum Zitat Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA III, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298:405–412PubMedCrossRef Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA III, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298:405–412PubMedCrossRef
31.
Zurück zum Zitat Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS (2009) Long term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm 6:993–997PubMedCrossRef Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS (2009) Long term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm 6:993–997PubMedCrossRef
32.
Zurück zum Zitat McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 59:971–975PubMedCrossRef McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 59:971–975PubMedCrossRef
33.
Zurück zum Zitat McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE (1988) Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiolol 11:147–153CrossRef McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE (1988) Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiolol 11:147–153CrossRef
34.
Zurück zum Zitat McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR (2009) Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiolol 54:229–233CrossRef McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR (2009) Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiolol 54:229–233CrossRef
35.
Zurück zum Zitat Melacini P, Maron BJ, Bobbo F, Basso C, Tokajuk B, Thiene G, Iliceto S (2007) Evidence that pharmacologic strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 93:708–710PubMedCrossRef Melacini P, Maron BJ, Bobbo F, Basso C, Tokajuk B, Thiene G, Iliceto S (2007) Evidence that pharmacologic strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 93:708–710PubMedCrossRef
36.
Zurück zum Zitat Mohiddin SA, Begley D, Shih J, Fananapazir L (2000) Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. J Am Coll Cardiol 36:2270–2278PubMedCrossRef Mohiddin SA, Begley D, Shih J, Fananapazir L (2000) Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. J Am Coll Cardiol 36:2270–2278PubMedCrossRef
37.
Zurück zum Zitat Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42:873–879PubMedCrossRef Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42:873–879PubMedCrossRef
38.
Zurück zum Zitat Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F (1999) Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 33:2044–2051PubMedCrossRef Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F (1999) Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 33:2044–2051PubMedCrossRef
39.
Zurück zum Zitat Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F (2003) Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 41:315–321PubMedCrossRef Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F (2003) Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 41:315–321PubMedCrossRef
40.
Zurück zum Zitat Östman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U (2005) Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15:632–642PubMedCrossRef Östman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U (2005) Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15:632–642PubMedCrossRef
41.
Zurück zum Zitat Östman-Smith I, Wettrell G, Keeton B, Holmgren D, Ergander U, Gould S, Bowker C, Verdicchio M (2008) Age and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J 29:1160–1167PubMedCrossRef Östman-Smith I, Wettrell G, Keeton B, Holmgren D, Ergander U, Gould S, Bowker C, Verdicchio M (2008) Age and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J 29:1160–1167PubMedCrossRef
42.
Zurück zum Zitat Pablo Kaski JP, Tome Esteban MT, Lowe M, Sporton S, Rees P, Deanfield JE, McKenna WJ, Elliott PM (2007) Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy. Heart 93:372–374PubMedCrossRef Pablo Kaski JP, Tome Esteban MT, Lowe M, Sporton S, Rees P, Deanfield JE, McKenna WJ, Elliott PM (2007) Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy. Heart 93:372–374PubMedCrossRef
43.
Zurück zum Zitat Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H (2004) Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43:1843–1852PubMedCrossRef Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H (2004) Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43:1843–1852PubMedCrossRef
44.
Zurück zum Zitat Romero-Farina G, Candell-Riera J, Pereztol-Valdés O, Castell J, Aguadé S, Galve E, Palet J, Oller-Martínez G, Armadans L, Reina D, Soler-Soler J (2001) Myocardial perfusion SPECT and isotopic ventriculography in obstructive and non-obstructive hypertrophic myocardiopathy. Rev Esp Med Nucl 20:530–536PubMed Romero-Farina G, Candell-Riera J, Pereztol-Valdés O, Castell J, Aguadé S, Galve E, Palet J, Oller-Martínez G, Armadans L, Reina D, Soler-Soler J (2001) Myocardial perfusion SPECT and isotopic ventriculography in obstructive and non-obstructive hypertrophic myocardiopathy. Rev Esp Med Nucl 20:530–536PubMed
45.
Zurück zum Zitat Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ (1997) Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 96:2987–2991PubMed Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ (1997) Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 96:2987–2991PubMed
46.
Zurück zum Zitat Saumarez RC, Slade AK, Grace AA, Sadoul N, Camm AJ, McKenna WJ (1995) The significance of paced electrogram fractionation in hypertrophic cardiomyopathy: a prospective study. Circulation 91:2762–2768PubMed Saumarez RC, Slade AK, Grace AA, Sadoul N, Camm AJ, McKenna WJ (1995) The significance of paced electrogram fractionation in hypertrophic cardiomyopathy: a prospective study. Circulation 91:2762–2768PubMed
47.
Zurück zum Zitat Schiavone WA, Maliney JD, Lever HM, Castle LW, Sterba R, Morant V (1986) Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology. Pacing Clin Electrophysiol 9:476–481PubMedCrossRef Schiavone WA, Maliney JD, Lever HM, Castle LW, Sterba R, Morant V (1986) Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology. Pacing Clin Electrophysiol 9:476–481PubMedCrossRef
48.
Zurück zum Zitat Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Tajik AJ, Holmes DR (2003) Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 42:889–894PubMedCrossRef Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Tajik AJ, Holmes DR (2003) Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 42:889–894PubMedCrossRef
49.
Zurück zum Zitat Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:1778–1785PubMedCrossRef Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:1778–1785PubMedCrossRef
50.
Zurück zum Zitat Thomas HL, Morris-Thurgood J, Atherton J, McKenna WJ, Frenneaux MP (1998) Reflex responses of venous capacitance vessels in patients with hypertrophic cardiomyopathy. Clin Sci 94:339–346 Thomas HL, Morris-Thurgood J, Atherton J, McKenna WJ, Frenneaux MP (1998) Reflex responses of venous capacitance vessels in patients with hypertrophic cardiomyopathy. Clin Sci 94:339–346
51.
Zurück zum Zitat Wellens JHH, Bar FW, Vanagt EJ (1980) Death after ajmaline administration. Am J Cardiol 45:905PubMedCrossRef Wellens JHH, Bar FW, Vanagt EJ (1980) Death after ajmaline administration. Am J Cardiol 45:905PubMedCrossRef
52.
Zurück zum Zitat Woo A, Monakier D, Harris L, Hill A, Shah P, Douglas Wigle E, Rakowski H, Rozenblyum E, Cameron DA (2007) Determinants of implantable defibrillator discharges in high risk patients with hypertrophic cardiomyopathy. Heart 93:1044–1045PubMedCrossRef Woo A, Monakier D, Harris L, Hill A, Shah P, Douglas Wigle E, Rakowski H, Rozenblyum E, Cameron DA (2007) Determinants of implantable defibrillator discharges in high risk patients with hypertrophic cardiomyopathy. Heart 93:1044–1045PubMedCrossRef
53.
Zurück zum Zitat Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R (1998) Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death. N Engl J Med 339:1201–1209PubMedCrossRef Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R (1998) Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death. N Engl J Med 339:1201–1209PubMedCrossRef
54.
Zurück zum Zitat Zhu DWX, Sun H, Hill R, Roberts R (1998) The value of electrophysiologic study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 21:299–302PubMedCrossRef Zhu DWX, Sun H, Hill R, Roberts R (1998) The value of electrophysiologic study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 21:299–302PubMedCrossRef
Metadaten
Titel
Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events
verfasst von
Jeffrey P. Moak
Eric S. Leifer
Dorothy Tripodi
Saidi A. Mohiddin
Lameh Fananapazir
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 8/2011
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-011-9967-y

Weitere Artikel der Ausgabe 8/2011

Pediatric Cardiology 8/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.